Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Lajos Kemeny, M.D.
FDA Inspection
•Lajos Kemeny, M.D.•February 22, 2019

Lajos Kemeny, M.D. – FDA Inspection, Feb 22, 2019

Record Details

This FDA Inspection record concerns Lajos Kemeny, M.D., with an inspection on February 22, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Lajos Kemeny, M.D.
Inspection Date
February 22, 2019
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Stuart W. Russell (FDA Associated Person)
View Company Profile

ID · e72f1b60-6402-4934-98e1-fa9819ae7119

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1083280
FDA center
Human Drugs
Project area
Bioresearch Monitoring
Outcome
Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Lajos Kemeny, M.D.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.